0

Real-world evidence and value-based contracting – swipe left or swipe right?

As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, high-cost therapies. We are moving to a value-based system, with two of the biggest ideas for this decade becoming more… Continue Reading

0

Key Elements of a Real-World Evidence Generation Plan: Integration of Product Support Activities

Shelby CormanPharmerit International Real-world evidence is a key component of value demonstration for pharmaceuticals, diagnostic agents, and medical devices throughout the product lifecycle. Planning for real-world evidence needs early in the pre-launch period can allow for seamless integration of health… Continue Reading

0

Benchmarking Survey: Can we reduce procurement time in HEOR & RWE?

As healthcare moves towards an increased focus on outcomes and value, health economics & outcomes research (HEOR) and real-world evidence (RWE) are being used to guide value-based decisions, improve outcomes, reduce costs, and achieve market access. This move toward new… Continue Reading

0

Building Trust In Real World Evidence – From Regulators To Patients

Bill Fox Chief Strategist for Global Healthcare, Life Sciences, and Insurance MarkLogic     In a climate of growing consumer distrust for companies that have access to their personal information, organizations that generate real world evidence must join the likes… Continue Reading

0

Who Are the Real Change-Agents in Pharma Market Access? The Growing Role of Value Demonstration

Would you believe it if I said that in a few years, the term “HEOR” may go the way of man-buns and flip phones? While the man-bun joke about the terminology may be a slight exaggeration, our field is indeed undergoing… Continue Reading